Assay Detail
Functional
CHEMBL2363346
Review assay metadata, readout intent, target linkage, and publication context from the same page.
SANGER: Inhibition of human KP-N-RT-BM-1 cell growth in a cell viability assay.
25
Total Activities
25
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | KP-N-RT-BM-1 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Genomics of Drug Sensitity in Cancer screening data, Wellcome Trust Sanger Institute
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 25 | 5.39 | 6.88 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL514499 | GW843682X | — | 1 | 6.88 |
| CHEMBL513909 | BI-2536 | 2.0 | 1 | 6.87 |
| CHEMBL300389 | — | — | 1 | 6.83 |
| CHEMBL428647 | PACLITAXEL | 4.0 | 1 | 6.65 |
| CHEMBL509032 | TAE-684 | — | 1 | 6.48 |
| CHEMBL379300 | A-443654 | — | 1 | 6.04 |
| CHEMBL401930 | — | — | 1 | 5.84 |
| CHEMBL1256459 | TORIN1 | — | 1 | 5.80 |
| CHEMBL515416 | — | — | 1 | 5.60 |
| CHEMBL601719 | CRIZOTINIB | 4.0 | 1 | 5.57 |
| CHEMBL413 | SIROLIMUS | 4.0 | 1 | 5.10 |
| CHEMBL392695 | S-TRITYL-L-CYSTEINE | — | 1 | 4.90 |
| CHEMBL209148 | — | — | 1 | 4.83 |
| CHEMBL572878 | TOZASERTIB | 2.0 | 1 | 4.59 |
| CHEMBL483847 | — | — | 1 | 4.52 |
| CHEMBL213100 | — | — | 1 | 4.47 |
| CHEMBL64925 | MG-132 | — | 1 | 4.25 |
| CHEMBL217092 | SARACATINIB | 3.0 | 1 | 4.20 |
| CHEMBL941 | IMATINIB | 4.0 | 1 | 4.18 |
| CHEMBL197603 | — | — | 1 | 4.11 |
| CHEMBL1643959 | — | — | 1 | - |
| CHEMBL1242367 | — | — | 1 | - |
| CHEMBL5416410 | DASATINIB | 4.0 | 1 | - |
| CHEMBL450786 | PHA-665752 | — | 1 | - |
| CHEMBL535 | SUNITINIB | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL514499 | GW843682X | IC50 | = | 130.63 | nM | 6.88 |
| CHEMBL513909 | BI-2536 | IC50 | = | 136.12 | nM | 6.87 |
| CHEMBL300389 | — | IC50 | = | 148.04 | nM | 6.83 |
| CHEMBL428647 | PACLITAXEL | IC50 | = | 223.49 | nM | 6.65 |
| CHEMBL509032 | TAE-684 | IC50 | = | 331.23 | nM | 6.48 |
| CHEMBL379300 | A-443654 | IC50 | = | 910.79 | nM | 6.04 |
| CHEMBL401930 | — | IC50 | = | 1439.44 | nM | 5.84 |
| CHEMBL1256459 | TORIN1 | IC50 | = | 1565.51 | nM | 5.80 |
| CHEMBL515416 | — | IC50 | = | 2514.03 | nM | 5.60 |
| CHEMBL601719 | CRIZOTINIB | IC50 | = | 2701.22 | nM | 5.57 |
| CHEMBL413 | SIROLIMUS | IC50 | = | 7930.29 | nM | 5.10 |
| CHEMBL392695 | S-TRITYL-L-CYSTEINE | IC50 | = | 12653.89 | nM | 4.90 |
| CHEMBL209148 | — | IC50 | = | 14668.08 | nM | 4.83 |
| CHEMBL572878 | TOZASERTIB | IC50 | = | 25475.21 | nM | 4.59 |
| CHEMBL483847 | — | IC50 | = | 30088.53 | nM | 4.52 |
| CHEMBL213100 | — | IC50 | = | 33819.79 | nM | 4.47 |
| CHEMBL64925 | MG-132 | IC50 | = | 56663.77 | nM | 4.25 |
| CHEMBL217092 | SARACATINIB | IC50 | = | 63627.64 | nM | 4.20 |
| CHEMBL941 | IMATINIB | IC50 | = | 66636.6 | nM | 4.18 |
| CHEMBL197603 | — | IC50 | = | 77148.1 | nM | 4.11 |
| CHEMBL1643959 | — | IC50 | = | 152129.78 | nM | - |
| CHEMBL1242367 | — | IC50 | = | 143949.71 | nM | - |
| CHEMBL5416410 | DASATINIB | IC50 | = | 144723.93 | nM | - |
| CHEMBL450786 | PHA-665752 | IC50 | = | 137745.94 | nM | - |
| CHEMBL535 | SUNITINIB | IC50 | = | 136501.69 | nM | - |